Literature DB >> 8621222

Risk factors for adrenal cancer: an exploratory study.

A W Hsing1, J M Nam, H T Co Chien, J K McLaughlin, J F Fraumeni.   

Abstract

Adrenal cancer is a heterogeneous group of neoplasms with unknown etiology. In search of risk factors, we conducted a case-control study based on data from the 1986 National Mortality Followback Survey, which included a questionnaire sent to the next of kin of almost 20,000 deceased adults (age > or = 25 year) in the United States. Information was obtained on a large number of items, including use of cigarettes, alcohol, oral contraceptives (OCs), height and weight and food consumption patterns. A total of 176 subjects who died of adrenal cancer (88 men and 88 women) and 352 controls (176 men and 176 women) who died of causes unrelated to smoking, drinking or OCs (for female controls) were included in the study. Although information on histologic type was not available, most cases were estimated from incidence surveys to be adrenocortical carcinoma, with a small percentage being malignant pheochromocytoma or neuroblastoma. An increased risk was associated with heavy smoking (> or = 25 cigarettes/day) among men (odds ratio [OR] = 2.0, 95% confidence interval [CI] 1.0-4.4) but not women. No clear association was seen for alcohol use, height and weight or food consumption patterns in either sex. Among women, increased risks were found for ever users of OCs (OR = 1.8, 95% CI 1.0-3.2) and especially those who used them before age 25 (OR = 2.5, 95% CI 1.2-5.5). When the analysis was restricted to subjects with spousal respondents, more pronounced risks were seen for ever users of OCs and for those who used OCs before age 25. Our findings suggest that cigarette smoking and use of OCs may increase the risk of adrenal cancer, but additional studies are needed with more detailed information on risk factors and histologic type of adrenal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621222     DOI: 10.1002/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

2.  Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Authors:  Siyuan Zheng; Andrew D Cherniack; Ninad Dewal; Richard A Moffitt; Ludmila Danilova; Bradley A Murray; Antonio M Lerario; Tobias Else; Theo A Knijnenburg; Giovanni Ciriello; Seungchan Kim; Guillaume Assie; Olena Morozova; Rehan Akbani; Juliann Shih; Katherine A Hoadley; Toni K Choueiri; Jens Waldmann; Ozgur Mete; A Gordon Robertson; Hsin-Ta Wu; Benjamin J Raphael; Lina Shao; Matthew Meyerson; Michael J Demeure; Felix Beuschlein; Anthony J Gill; Stan B Sidhu; Madson Q Almeida; Maria C B V Fragoso; Leslie M Cope; Electron Kebebew; Mouhammed A Habra; Timothy G Whitsett; Kimberly J Bussey; William E Rainey; Sylvia L Asa; Jérôme Bertherat; Martin Fassnacht; David A Wheeler; Gary D Hammer; Thomas J Giordano; Roel G W Verhaak
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

Review 3.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

4.  Adiponectin receptor expression in human malignant tissues.

Authors:  Sharon H Chou; Sofia Tseleni-Balafouta; Hyun-Seuk Moon; John P Chamberland; Xiaowen Liu; Nikolaos Kavantzas; Christos S Mantzoros
Journal:  Horm Cancer       Date:  2010-06       Impact factor: 3.869

Review 5.  Partial adrenalectomy: underused first line therapy for small adrenal tumors.

Authors:  Deborah R Kaye; Benjamin B Storey; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

Review 6.  Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy-a population-based study and review of the literature.

Authors:  S Atallah; H Al-Assaf; Y Xu; S El-Sayed
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

Review 7.  Adrenal tumours are more predominant in females regardless of their histological subtype: a review.

Authors:  François Audenet; Arnaud Méjean; Emmanuel Chartier-Kastler; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-01-09       Impact factor: 4.226

Review 8.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

9.  Adrenal incidentaloma in pregnancy: clinical, molecular and immunohistochemical findings.

Authors:  F Fallo; V Pezzi; N Sonino; G Altavilla; L Barzon
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

10.  Comparative effects of prolactin versus ACTH, estradiol, progesterone, testosterone, and dihydrotestosterone on cortisol release and proliferation of the adrenocortical carcinoma cell line H295R.

Authors:  Sukanya Jaroenporn; Chie Furuta; Kentaro Nagaoka; Gen Watanabe; Kazuyoshi Taya
Journal:  Endocrine       Date:  2008-05-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.